Akụkọ

Fluxergy bụ onye tọrọ ntọala nke Mmemme Mmepụta Mmepụta (IPP) Wyss Diagnostic Accelerator (Wyss DxA).Wyss DxA bụ atụmatụ sitere na Wyss Institute na Mahadum Harvard iji mepụta na wepụta teknụzụ nyocha nke ọma iji gboo mkpa ụlọ ọgwụ na-enweghị nsogbu na nyocha, nyocha, prognosis na ọgwụgwọ.Site na ntinye aka na IPP, Fluxergy na ndị ọkachamara na-ahụ maka ụlọ ọgwụ, ndị nchọpụta, ndị injinia, ụlọ ọrụ na-enye ego, ndị ọrụ ebere, ụlọ ọrụ gọọmentị, na ndị mmekọ ụlọ ọrụ.
"Ụdị ihe ịga nke ọma maka Wyss Diagnostic Accelerator na-azọpụta ndụ site n'inye nyocha nke ziri ezi na ọnụ ala, nke ahụ bụkwa ọrụ anyị," Dr. Rushdi Ahmad, Onye isi nke Wyss DxA kwuru.
Wyss DxA bụ Ahmad na Dr. David Walt na-edu.Walt bụ onye isi ngalaba na Wyss Institute, prọfesọ nke pathology na Brigham Hospital na Women's Hospital, na onye na-arụkọ ọrụ sayensị nke ọtụtụ ụlọ ọrụ sayensị ndụ.Site na itinye aka na mmemme ahụ, Fluxergy ga-arụ ọrụ n'ime IPP iji mee ka nchọpụta, mmepe na nnyefe nke ngwọta nyocha na mpaghara ebe ọ dị mkpa na-adịghị.
“Mgbe mbụ mụ na ndị mbụ mụ na ha na-akpakọrịta, obi dị m ụtọ.Anyị nwere oghere juputara na ịdị arọ sayensị na azụmahịa iji mejuputa mgbanwe, ọkachasị iji kwekọọ mkpa na-emezughị na teknụzụ achọrọ.Ohere iji sonye n'otu egwuregwu nke ahụmịhe nke njikọta nke ndị ọgaranya, ndị nwere mmasị pụrụ iche na nka dị iche iche: ngwa na ahụike mmadụ, ọgwụ anụmanụ na nchekwa nri, ọnụnọ ụwa n'ahịa ọ bụla na mkpuchi nke telemedicine, nchọpụta nyocha, nchọpụta ọgwụ. na ahụike dijitalụ, "Tej Patel, CEO na onye nchoputa nke Fluxergy kwuru.
Fluxergy bu n'obi iji ikpo okwu nyocha ya nke otutu-modal dị ka onye mmekọ OEM iji mepụta oghere ule multi-ohm na-ejikọta njikọ nke protein, transcripts na metabolites n'ime mbinye aka pụrụ iche iji mee ka ndị ọrịa mara nsonaazụ ọgwụgwọ.Enwere ike ịhụ ihe atụ nke ngwa ahụike mmadụ na ọrịa na-efe efe, ọrịa ọbara na-adịghị ala ala, kansa, sepsis, na ọrịa akụrụ na-adịghị ala ala.Ka ọ dị ugbu a, ngwaọrụ ahụike nwere ike ịnwe oke na ikpebi otu ụdị oke (ya bụ, immunoassay, kemistri, ma ọ bụ PCR).Ezubere sistemu mgbanwe Fluxergy iji rụọ PCR, immunoassay, biochemistry na ọnụ ọgụgụ cell n'otu ikpo okwu enyi na enyi.Na nlekọta ahụike, Fluxergy bu n'obi inye aka melite syndromic na ọnọdụ ule panel ma mee ka ha dị na obere ụlọ ọgwụ, ụlọ ọrụ dọkịta, ebe a na-elekọta ndị agadi na ndị na-azụ ahịa maka ule ndị ọzọ ọkaibe, site na panel metabolic izugbe ruo ule nyocha sepsis.Nke a bụ mgbasawanye nke akụrụngwa ụlọ nyocha etiti ga-eme ka mkpebi ụlọ ọgwụ ngwa ngwa dabere na ozi ụlọ nyocha.
Dr. Ahmed mechiri nzukọ ngwụcha afọ ahụ site n'ịsị, "Na Wyss Diagnostic Accelerator, otu a nwere ọhụụ na-enweghị atụ na nke pụrụ iche iji mee ka nchọpụta nyocha nweta onye ọ bụla."
Fluxergy bụ ụlọ ọrụ ngwaọrụ ahụike ọkachamara na teknụzụ nchọta isi ihe iji nye nyocha dị ọnụ ala n'ọnọdụ ọ bụla.Sistemụ Fluxergy na-eji microfluidics nwe ya na sistemu ihe mmetụta jikọtara ọnụ nke ukwuu iji mepụta ikpo okwu nnwale multimodal na-agbanwe agbanwe yana ọnụ ahịa.Fluxergy bụ ISO 13485 yana MDSAP kwadoro maka mmepụta IVD. N'ichepụta Fluxergy na R&D campus gbasara 90,000 sq.ft. N'ichepụta Fluxergy na R&D campus gbasara 90,000 sq.ft.Ụlọ ọrụ mmepụta ihe na nyocha nke Fluxergy na-ekpuchi mpaghara nke 90,000 sq. ft.Ụlọ ọrụ mmepụta ihe na nyocha Fluxergy na-ekpuchi 90,000 square ụkwụ.na Irvine, California.Fluxergy Europe GMBH dabeere na Aschaffenburg, Germany.E hiwere Fluxergy Inc. na 2013 site na nkwado ego nke onye na-etinye ego na onye nchoputa Kingston Technology, John Tu.
Sistemụ Nnwale Fluxergy Diagnostic nwere kaadị Fluxergy, katrij ule nyocha-na-a-chip enwere ike iwepu, onye nyocha Fluxergy, yana sọftụwia Fluxergy Works nke na-agba usoro ule iji lelee na ịkọwa data ule.Kaadị Fluxergy bụ multi-modal (nke pụtara ụdị ule diagnostic dị iche iche nwere ike ime n'otu oge, dị ka PCR, immunochemistry, kemịkalụ, wdg) ma na-emepụta ya ma jiri bọọdụ sekit e biri ebi (PCB), na-eme ka ha dị oke egwu. na-eri-irè.na extensibility.Microfluidics.Ọrụ Fluxergy na-enye ohere ka òtù dị iche iche jikọọ ọtụtụ ngwaọrụ na igwe ojii dịka netwọk nwere ike ịkwado.
Ngwa ule Fluxergy POC PCR COVID-19 dị naanị maka ịzụrụ n'ahịa EU na ahịa ọ bụla ọzọ na-anabata akara CE dị ka nnabata usoro iwu ziri ezi.
Fluxergy na-etolitekwa akụkụ iku ume na-enweghị CLIA, panel mbufụt, ma na-ere ahịa ọtụtụ ngwaahịa maka ụlọ ọgwụ equine na ahịa nchekwa nri.
Kpọtụrụ onye edemede: E depụtara ozi kọntaktị na ozi ọha dị na akuku aka nri elu nke akwụkwọ akụkọ niile.
© Nwebiisinka 1997-2015, Vocus PRW Holdings, LLC.Vocus, PRWeb na Publicity Wire bụ ụghalaahịa ma ọ bụ ụghalaahịa edenyere n'akwụkwọ ikikere nke Vocus, Inc. ma ọ bụ Vocus PRW Holdings, LLC.